about
OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataractOPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypesMulti-system neurological disease is common in patients with OPA1 mutationsGene structure and chromosomal localization of mouse Opa1 : its exclusion from the Bst locusHereditary optic neuropathies: from clinical signs to diagnosisWhy mitochondria must fuse to maintain their genome integrityBlocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.Resveratrol Directly Binds to Mitochondrial Complex I and Increases Oxidative Stress in Brain Mitochondria of Aged MiceRecessive Mutations in RTN4IP1 Cause Isolated and Syndromic Optic NeuropathiesNuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophyThe human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane spaceMitochondrial dynamics and disease, OPA1Early-onset Behr syndrome due to compound heterozygous mutations in OPA1Recessive TBC1D24 Mutations Are Frequent in Moroccan Non-Syndromic Hearing Loss PedigreesBiallelic Variants in UBA5 Reveal that Disruption of the UFM1 Cascade Can Result in Early-Onset EncephalopathyLoss of function of Ywhah in mice induces deafness and cochlear outer hair cells' degeneration.Dominant optic atrophy.Mitochondrial fusion is frequent in skeletal muscle and supports excitation-contraction couplingMutation in NDUFA13/GRIM19 leads to early onset hypotonia, dyskinesia and sensorial deficiencies, and mitochondrial complex I instability.Homozygous deletion related to Alu repeats in RLBP1 causes retinitis punctata albescens.Novel compound heterozygous MYO7A mutations in Moroccan families with autosomal recessive non-syndromic hearing lossOPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.Impairment of visual function and retinal ER stress activation in Wfs1-deficient mice.Martinique Crinkled Retinal Pigment Epitheliopathy: Clinical Stages and Pathophysiologic Insights.Increase in Cardiac Ischemia-Reperfusion Injuries in Opa1+/- Mouse Model.A Nontargeted UHPLC-HRMS Metabolomics Pipeline for Metabolite Identification: Application to Cardiac Remote Ischemic Preconditioning.OPA1 functions in mitochondria and dysfunctions in optic nerve.OPA1-associated disorders: phenotypes and pathophysiology.OPA1 (dys)functions.A novel mutation in the TMC1 gene causes non-syndromic hearing loss in a Moroccan family.Molecular analysis of the TMPRSS3 gene in Moroccan families with non-syndromic hearing loss.A dominant mutation in MAPKAPK3, an actor of p38 signaling pathway, causes a new retinal dystrophy involving Bruch's membrane and retinal pigment epithelium.Neurotoxicity of insecticides.TRPV4 channels mediate the infrared laser-evoked response in sensory neurons.Increased steroidogenesis promotes early-onset and severe vision loss in females with OPA1 dominant optic atrophy.Mediterranean Founder Mutation Database (MFMD): Taking Advantage from Founder Mutations in Genetics Diagnosis, Genetic Diversity and Migration History of the Mediterranean Population.Pyp3 PTPase acts as a mitotic inducer in fission yeast.In vivo time-lapse imaging of mitochondria in healthy and diseased peripheral myelin sheath.Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy.Genetic and molecular analysis of the CLDN14 gene in Moroccan family with non-syndromic hearing loss.
P50
Q24302329-4CD5C219-2516-4CE7-9775-4B8DF9BD5477Q24304868-2C02BA75-B3D0-40DC-934A-3184485A6AC7Q24619312-7F9056B0-908C-4F23-87FC-61434E9783C1Q24800759-036CB827-2FB8-4AE8-9D5E-8AB95513A298Q26852137-14E3F640-DEDB-413E-A4AB-43C64C239588Q27022853-08147349-EFDA-4D3B-8629-64FAAB028038Q27330087-7408BA2A-DC7A-4A0F-B0BC-B35BF5DE9725Q27335789-815AD286-4502-4DCB-98B6-F3AB66875722Q28115704-AD604FDE-7A1F-4FC6-82F1-115476C2A476Q28140286-108A84D4-DA98-4BAA-8908-2AAA8AEE5E42Q28215023-C0A0BDC2-190E-43CE-81DF-D5641AFAFB9BQ28243097-EBCA3BF4-2BF3-44D4-9B5B-F9991F3534EFQ28243663-E4022EA7-2430-4123-A526-9AF461F6DCBAQ28548025-9BD3EF47-8D15-44A7-8C2E-21305F1D08AEQ29147524-7BF9AF41-A4BA-456C-ACF7-5666BF870ADAQ30382075-9F1FCDBF-E3E3-4281-8FA2-9356FEB09B01Q30459784-49D0795C-0E39-49D5-A30D-DEF2C2A0BFBEQ30577237-5B14D92A-D965-4E76-B1C1-E559BE8EFC2AQ32884383-781E0FE9-D1A8-48D1-849D-96D1ED6EF11EQ33261575-2E349D2D-EFBF-4E94-B9EA-F79568E0EBE5Q33637518-F463838A-847E-4A36-9F67-BDE7610DAE46Q33637518-FCDF82F7-474B-4938-992E-721110C0BF1DQ34539197-E5C0B13F-3B83-4990-9E9A-2B20CC3B28C3Q35167762-511AEC3A-1CF9-4DC4-B574-79CA2D5EF200Q36090558-DFAA4AD4-1195-46B9-962D-A08A04E495F8Q36159289-21F08483-DC94-402F-A7BE-3361F609AAA6Q36227905-D79F72FA-19D8-4695-A92C-8D3B43470C45Q37457225-CB08EA51-962E-46EE-BBD8-D287C1D23667Q37457238-00407072-E4EE-48BA-8D56-E1BEB6CF9988Q37665952-DC6E34F6-887A-406F-B57E-73467BC13886Q38889301-DEEE4C50-8A8B-4575-8332-DFAEC276FF35Q38939455-6D9A6F16-174C-40AC-BD92-B94663F083D3Q39248006-DA24F269-A415-4EA3-8242-A4C0B1C47775Q39334713-AFF67BE9-B2E7-4CC2-9131-75E398FF870BQ39637320-9EF3815F-FE09-4FBB-8193-B4F3D02E143BQ39710935-D7B59B8D-4DD7-486A-B4C9-5282C1F8E304Q40738080-1CA3B9E3-A116-4D32-8D54-4259D401420CQ41543204-6EB528C6-56E7-4E12-9FE0-7FB0201A9E6AQ41703197-A1E552A9-7747-45BB-87AE-7EC8469C4D0BQ41825073-C5B0FE21-2215-45E6-B1C2-CA60AD8644B9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Guy Lenaers
@ast
Guy Lenaers
@en
Guy Lenaers
@es
Guy Lenaers
@nl
type
label
Guy Lenaers
@ast
Guy Lenaers
@en
Guy Lenaers
@es
Guy Lenaers
@nl
prefLabel
Guy Lenaers
@ast
Guy Lenaers
@en
Guy Lenaers
@es
Guy Lenaers
@nl
P106
P31
P496
0000-0003-2736-3349